mesalamine has been researched along with ursodeoxycholic acid in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Batta, AK; Salen, G; Shefer, S; Tint, GS; Xu, G | 1 |
| Kikuchi, S; Kisara, N; Komatsu, K; Maruhama, Y; Shimosegawa, T; Toyota, T; Uchi, M; Ueno, Y | 1 |
| Aki, H; Goto, M; Okamoto, Y; Yamamoto, M | 1 |
| Fukaura, Y; Nakai, K; Narisawa, T; Takeba, N | 1 |
| Croog, VJ; Itzkowitz, SH; Ullman, TA | 1 |
| Vetter, C | 1 |
| Burakoff, R; Levine, JS | 1 |
| Farinati, F; Herszényi, L; Miheller, P; Tulassay, Z | 1 |
| Eksteen, B; Goh, J; Kane, K; Love, M; Low, A; Walt, R | 1 |
| Miao, XP; Ouyang, Q; Sun, XN; Wei, H | 1 |
| Ardizzone, S; Danese, S; Gasche, C; Hernández, V; Kariv, R; Marti-Gallostra, M; Myrelid, P; Sebastian, S; Spinelli, A; Toruner, M; Tsianos, E; van der Meulen-de Jong, AE; Yuksel, ES | 1 |
| Han, SH; Lee, J | 1 |
| Chapman, CG; Rubin, DT | 1 |
| Kowdley, KV; Lashner, B; Rao, BB | 1 |
| Bergquist, A; Bottai, M; Höijer, J; Söderberg-Löfdal, K; Stokkeland, K | 1 |
| Beaufrère, A; Céruti, H; Coffin, B; Dussaux, C; Gervais, A; Guilbaud, L; Kayem, G; Maisonneuve, E; Mandelbrot, L | 1 |
10 review(s) available for mesalamine and ursodeoxycholic acid
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chemoprevention of colorectal cancer in ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium, Dietary; Chemoprevention; Cholagogues and Choleretics; Colitis, Ulcerative; Colorectal Neoplasms; Folic Acid; Hematinics; Humans; Mesalamine; Ursodeoxycholic Acid | 2003 |
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colorectal Neoplasms; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Treatment Outcome; Ursodeoxycholic Acid; Vitamin B Complex | 2007 |
Chemoprevention of colorectal cancer: feasibility in everyday practice?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Chemoprevention; Clinical Trials as Topic; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Dietary Supplements; Family Practice; Feasibility Studies; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mesalamine; Ursodeoxycholic Acid | 2008 |
Crohn's disease and primary sclerosing cholangitis: a case report and review of the literature.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; CA-19-9 Antigen; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Colonoscopy; Comorbidity; Crohn Disease; Humans; Liver; Liver Function Tests; Liver Transplantation; Male; Mesalamine; Prognosis; Ursodeoxycholic Acid | 2012 |
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).
Topics: Age of Onset; Anticarcinogenic Agents; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Congresses as Topic; Crohn Disease; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Mesalamine; Risk Factors; Survival Rate; Time Factors; Ursodeoxycholic Acid | 2014 |
[Chemoprevention of colorectal cancer in inflammatory bowel disease].
Topics: Anti-Inflammatory Agents; Chemoprevention; Colorectal Neoplasms; Folic Acid; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Ursodeoxycholic Acid | 2014 |
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2014 |
Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Topics: Cholangitis, Sclerosing; Colonoscopy; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Liver Function Tests; Liver Transplantation; Mesalamine; Risk Factors; Ursodeoxycholic Acid | 2018 |
12 other study(ies) available for mesalamine and ursodeoxycholic acid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid.
Topics: Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport, Active; Clostridium perfringens; Colonic Polyps; Humans; Inflammatory Bowel Diseases; Intestinal Absorption; Intestinal Mucosa; Intestines; Mesalamine; Rats; Ursodeoxycholic Acid | 1998 |
Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Betamethasone; Bile Ducts; Biopsy; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Colitis, Ulcerative; Colonoscopy; Disease Progression; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver; Liver Function Tests; Male; Mesalamine; Prednisolone; Ursodeoxycholic Acid | 2000 |
Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chenodeoxycholic Acid; Colitis, Ulcerative; Disease Models, Animal; Guinea Pigs; Mesalamine; Ursodeoxycholic Acid | 2001 |
Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.
Topics: Animals; Anticarcinogenic Agents; Bile Acids and Salts; Colonic Neoplasms; Female; Mesalamine; Methylnitrosourea; Precancerous Conditions; Rats; Rats, Inbred F344; Ursodeoxycholic Acid | 2002 |
[Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Humans; Immunosuppressive Agents; Mesalamine; Recurrence; Risk Factors; Time Factors; Ursodeoxycholic Acid | 2005 |
Understanding of chemoprophylaxis and concordance in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholagogues and Choleretics; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Patient Compliance; Patient Education as Topic; Surveys and Questionnaires; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
[Gastroenterology and hepatology. Using established therapies].
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Evidence-Based Medicine; Fatty Liver, Alcoholic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Mesalamine; Ursodeoxycholic Acid; Weight Loss | 2010 |
Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Crohn Disease; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Male; Mesalamine; Middle Aged; Mortality; Proportional Hazards Models; Protective Factors; Registries; Sweden; Ursodeoxycholic Acid | 2019 |
Intrahepatic cholestasis of pregnancy associated with azathioprine: A case series.
Topics: Adult; Azathioprine; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Colitis, Ulcerative; Crohn Disease; Drug Substitution; Female; France; Humans; Immunosuppressive Agents; Mesalamine; Pregnancy; Pregnancy Complications; Pruritus; Remission, Spontaneous; Retrospective Studies; Ursodeoxycholic Acid; Withholding Treatment | 2021 |